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In the first paper of this series (1), an examination was made of the 
theory that  the outcome in  pneumonia largely  depended upon  (1) 
the  quantity  of  specific  carbohydrate  which was  produced by  the 
pneumococcus growing and autolyzing in the body and which by its 
antibactericidal  action  protected  the  pneumococcus from phagocy- 
tosis;  and  (2)  the  quantity  of  carbohydrate-neutralizing  antibody 
either produced naturally in the body as a  result of infection or arti- 
ficially introduced by  injection. 
On this theory, excess of the carbohydrate would result in death, 
excess  of  the  antibody  in  recovery.  When  the  theory was  tested 
quantitatively, it broke  down at  once.  For it was  found that  the 
antibactericidal action of the carbohydrate was so easily neutralized 
by the specific antibody that the introduction of 200 cc. of antiserum 
at any stage of the disease would be more than sufficient to neutralize 
any conceivable amount of carbohydrate that could be present in the 
body.  According to the theory then, no serum-treated patient could 
possibly die.  Unhappily this is not the case. 
Up  to  this  point in  the  investigation,  the  author had made the 
natural assumption that the pure carbohydrate (isolated by Avery and 
Heidelberger (2)  in their researches on type specificity) is present as 
such in the washings of the organisms, in culture fluids, and in the body 
during pneumonia.  And in  favour  of  this  assumption is  the  well 
known fact that the washings of the organisms, the culture fluids in 
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which they have grown, and often the urine in the course of the disease 
contain a  substance which precipitates specifically with the antiserum 
in the same manner as does the purified carbohydrate.  This suggests 
that the substance in the washings of the pneumococcus, in the culture 
fluids, and in the urine, is identical with the purified carbohydrate, but 
does not prove it  beyond doubt.  The possibility remains that  the 
reacting substance in the washings of the pneumococcus, culture fluid, 
or  urine  contains  the  carbohydrate,  but  is  more  complex and  less 
stable  than  the  carbohydrate itself.  Whether  the  carbohydrate is 
isolated from the pneumococci themselves or from the broth in which 
the organisms have grown and autolyzed, many rather severe chemical 
manipulations have to be carried out before it can be separated from 
other substances.  If there were a  parent substance, which was less 
stable than the carbohydrate, there would be ample occasion for its 
breakdown.  That  a  parent  substance  exists  in  the  pneumococcus 
itself is suggested by the fact that the carbohydrate is not antigenic, 
type-specific antibodies  being  produced only by injection  of intact 
pneumococci or of carbohydrate artificially synthesized with a protein 
(3).  However a pneumococcus autolysate resembles the carbohydrate 
in that it does not give rise to type-specific antibodies on injection, but 
again this does not prove beyond doubt  that  the type-specific pre- 
cipitinogen  in  the  autolysate and  the  carbohydrate are  indentical. 
The possibility that the reacting substance in the autolysate is more 
complex and less stable than the carbohydrate--perhaps a  substance 
intermediate between the antigenic carbohydrate compound in  the 
intact pneumococcus and the carbohydrate itself--was forced on the 
author as the most likely explanation of some experiments which will 
now be presented. 
When working with a  Berkefeld filtrate of a  culture of Type III 
pneumococcus in  0.5  per  cent rabbit  blood  broth,  which had  been 
incubated for 5 days, it was found that this filtrate had a strong anti- 
bactericidal effect, which was only neutralized by strong concentrations 
of Type III  antiserum in  a  bactericidal test.  This  was in marked 
contrast to the antibactericidal effect of Type III carbohydrate, which 
in far stronger concentration than could be present in the filtrate is 
neutralized  by  a  considerably  weaker  concentration  of  antiserum. 
These  bactericidal  experiments,  the  results  of which  are  shown  in HUGH  K.  WARD  521 
Tables I  and II, were carried out in the manner already described in 
Paper I  (1). 
In Tables I  and II the last column shows the bactericidal action of 
the blood alone, and in the immediately preceding columns it will be 
noted that in the concentrations employed the broth filtrate and the 
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carbohydrate  have  completely  inhibited  this  bactericidal  action. 
In Table I a prozone with antiserum concentrations of 1/16 and 1/160 
is seen.  The prozone in these neutralization experiments can always 
be recognized by the partial growth of the organisms.  It is always 
associated with the formation of a specific precipitate, and if the two 522  MECHANISM  OF  PNEUMOCOCCUS  IMMUNITY.  II 
reacting substances  are  mixed  and  the precipitate  removed  before 
adding the mixture to the blood, a sterile series of tubes results, show- 
ing that the prozone is really a zone of neutralization, which is masked 
by  the  inhibiting  action  of  the  precipitate.  The  third  column  of 
Table  I  shows  that  an  antiserum  concentration of  1/1,600  has  no 
neutralizing effect on the filtrate. 
In Table II, a  prozone with antiserum concentrations of 1/16 and 
1/160 is followed by a  series of tubes where an antiserum concentra- 
tion of 1/1,600  has obviously neutralized the antibactericidal action 
of the carbohydrate.  And a certain amount of neutralization is even 
seen with a  1/16,000  concentration of the antiserum. 
From a  comparison of the two tables, it is clear that it requires at 
least ten times more antiserum to neutralize the broth  filtrate than 
it does to neutralize the carbohydrate.  Naturally the first explana- 
tion  to  account for this  result  would be  that  the  concentration of 
specific carbohydrate in the broth filtrate is stronger than  that used 
in the experiment shown in Table II.  As a  matter of fact however, 
if it is the carbohydrate in the filtrate, titration ghows it to be very 
much weaker.  When  the broth  filtrate is  titrated out  against  the 
antiserum the end-point is reached at 1/40.  A similar titration of the 
pure  carbohydrate  gives  an  end-point  of  1/8,000,000.  A  simple 
calculation Shows  that the concentration of the carbohydrate in the 
filtrate, if it is the pure carbohydrate, cannot be higher than 1/200,000, 
which means 1/200,000  X  1/16,  or  1/3,200,000  in  the actual tubes 
used in  the experiment.  And  this  figure has to  be  compared with 
the carbohydrate concentration of  1/16,000  used in  the experiment 
shown in Table  II.  It can, moreover be shown experimentally that 
a concentration of 1/3,200,000 of the pure carbohydrate has little or no 
antibactericidal effect on the blood, presumably being neutralized by 
the natural antibody in the serum. 
The second obvious explanation is that the antibactericidal effect 
is due to a  non-specific substance present in the broth filtrate.  But 
this cannot be the case, because the filtrate of Pneumococcus Type 
III has no antibactericidal effect at all, if Type I or Type II pneumo- 
cocci are used in the test. 
A  third  explanation  is  that  there  is  another  type-specific  anti- 
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carbohydrate.  Enders (4) has recently shown that there is a  second 
type-specific substance in  the autolysate of  pneumococci, and that 
this  substance  has  no  relation  to  the  carbohydrate.  Experiment 
has shown however (see Table IV)  that if a  carbohydrate-absorbed 
antiserum  is  used  in  a  filtrate  neutralization  test,  such  an  anti- 
serum is quite  definitely weaker in its neutralizing  power  than  the 
unabsorbed  antiserum.  This  would indicate  that  the  substance  in 
the filtrate which is responsible for the antibactericidal effect is related 
to  the carbohydrate and  not to  the second type-specific substance, 
because Enders has demonstrated that the precipitation titre of the 
antibody against the second type-specific substance is not affected by 
absorbing  antiserum with  the  specific carbohydrate. 
There remains the fourth possibility that the active substance in the 
filtrate is an intermediate substance between the antigenic carbohy- 
drate complex in the pneumococcus itself and the pure carbohydrate. 
It is admitted that the only evidence--and that indirect--connecting 
the filtrate substance with the pure carbohydrate is the above men- 
tioned experiment with the carbohYdrate-absorbed antiserum.  This 
hypothetical intermediate  substance  would  be  more  complex,  less 
stable, and as has been seen, much more difficult to neutralize than the 
pure carbohydrate.  Actually, if a  comparison is made on the basis 
of the precipitinogen content of the filtrate and the pure carbohydrate 
it requires at least one thousand times as much antiserum to neutralize 
the antibactericidal effect of the filtrate as it does the same effect of the 
carbohydrate.  The reason for this  is  quite obscure at present.  It 
may lie in the nature of the union with the antibody, perhaps irrevers- 
ible in the case of the filtrate substance, and reversible under certain 
conditions in the case of the carbohydrate.  A closely related problem 
is the explanation of why it is so difficult--or rather impossible--to 
remove the protective power from an antiserum by absorbing with the 
specific carbohydrate, and so easy if whole pneumococci are used as 
the absorbing agent.  In both these problems, considerable evidence 
has already been advanced in these papers that only one antibody is 
concerned--the anticarbohydrate antibody. 
The relation between the active substance in  the Type III broth 
filtrate and Type III pneumonia would be largely theoretical unless 
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present in the lesion of Type III pneumonia.  Through the courtesy 
of the Boston City Hospital, a pneumonic lung was obtained from an 
autopsy of a  case of Type III pneumonia.  The purulent fluid was 
expressed from the lung as  thoroughly as possible,  diluted with an 
equal part of saline solution, and centrifuged.  The supernatant fluid 
was passed through a large Berkefeld filter, and the filtrate stored in 
the ice box.  Table III shows the result of testing the antibactericidal 
action of the lung filtrate, and also the neutralizing effect of Type III 
antiserum on  this  action.  A  fairly weak concentration of the lung 
filtrate is  used,  because with  a  stronger  concentration, one cannot 
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show dearly that the antiserum has any neutralizing effect at all.  The 
bactericidal technique already described is used. 
In the last column of Table III, the bactericidal effect of the blood 
alone may be observed, and in the preceding column the anfibacteri- 
cidal effect of the lung filtrate.  The partial growth in the first column 
indicates that the lung filtrate has been neutralized by this concentra- 
tion of antiserum.  The greater growth in the second column indicates 
partial neutralization.  But the third and fourth columns show that 
weaker concentrations of antiserum have no neutralizing effect.  This 
experiment, then,  parallels  the one conducted with Type III broth 
filtrate. 
The antihactericidal action of the lung filtrate cannot be due to any 
non-type-specific substance, because even with a  ten times stronger ~-~GH K.  WARD  525 
concentration of lung  filtrate,  there  is  no  antibactericidal  effect if 
Type I  or Type II pneumococci are used in the test.  The antibac- 
tericidal action of the lung filtrate cannot be due to the presence of 
pure carbohydrate, because, by precipitinogen titration, it was found 
that the concentration of carbohydrate, if it were carbohydrate, could 
be no higher than 1/320,000,  and this concentration of pure carbohy- 
drate is neutralized by a weaker concentration of antiserum even than 
was used in this test. 
The  neutralizing  effect of  Type  III  antiserum  which  had  been 
absorbed with Type III carbohydrate was then investigated, with the 
result shown in Table IV.  As a control, the effect of the unadsorbed 
serum was again tested, and also the effect of removing the precipitate 
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between the  filtrate  and  the  unadsorbed  serum  before adding  the 
mixture to the tubes.  It may be noted here that the specific precipitate 
formed on adding undiluted antiserum to the undiluted lung filtrate 
is so bulky that even after centrifugation, it is difficult to obtain any 
supernatant fluid.  No precipitate was however seen on adding the 
carbohydrate-absorbed antiserum to  the lung filtrate. 
The third column in Table IV shows clearly that the effect of this 
concentration of lung filtrate is really neutralized by the 1/16 concen- 
tration of antiserum, the partial growth seen in  the second column 
being due to inhibition of the bactericidal power of the blood by the 
specific precipitate present.  The first column shows that when the 
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with the carbohydrate, the neutralizing effect on the lung filtrate is 
very definitely weakened also.  As with the Type III broth filtrate, 
this evidence points to the active substance in the lung filtrate being a 
type-specific substance related to, but not identical with the specific 
carbohydrate. 
Assuming that none of the active substance was lost in filtration, it 
would require about  four times the quantity of a  strong Type III 
antiserum  to  completely neutralize  the  antibactericidal  effect of  a 
given amount of the fluid in this particular lung.  But, although the 
lungs in this instance contained at the very least half a  litre of this 
fluid, we have no means of ascertaining during life the amount of the 
concentration of the active substance in the lesion, and therefore it is 
impossible  to  say whether the  presence of  a  large  amount  of  this 
powerful substance at autopsy explains why the Type III antiserum 
is  ineffective therapeutically.  However the  behaviour  of  this  sub- 
stance revives the hope that was dimmed by the examination of the 
behaviour of the specific carbohydrate--the hope that some day the 
outcome in pneumonia may be largely explained in terms of a  known 
product of the pneumococcus and a known antibody which neutralizes 
that  product.  The  evidence presented here is  suggestive  that  the 
antibactericidal substance in the Type III broth filtrate and the Type 
III lung filtrate is the sought for product of the pneumococcus, but 
the evidence is not strong enough to justify a more definite claim than 
that. 
While these experiments were in progress, Dr. Sutliff of the Boston 
City Hospital kindly supplied a specimen of defibrinated blood from a 
convalescent case  of Type  III  pneumonia,  the  blood  being  drawn 
about 5 or 6 days after the crisis.  It was thought that the action of 
convalescent blood on the specific carbohydrate, on the broth filtrate, 
and on the lung filtrate might throw some light on the natural mecha- 
nism of recovery and perhaps give a  hint as to the method to be at- 
tempted in serum therapy.  Table V  shows the result of this experi- 
ment.  The same technique was employed  with the convalescent blood 
as with the normal blood. 
In Table V,  the last column shows that the convalescent blood is 
strongly bactericidal, and the third and fourth columns demonstrate 
that the blood was able in addition to neutralize a  considerable con- HUOH  K. WARD  527 
centration of Type III carbohydrate.  The complete sterility indicates 
that the concentration of precipitin (anticarbohydrate antibody) was 
weak, because had it been strong, a precipitate would have formed on 
the addition of the carbohydrate, and all the organisms would not have 
been killed--see Table  II.  Yet despite this  weakness in precipitin 
content, the first and second columns of Table V show that the con- 
valescent blood was able to neutralize the lung filtrate fairly well, and 
the broth filtrate very well.  The only way that it is possible to parallel 
these results with a  mixture of normal blood and antiserum is to use 
a much stronger concentration of antibody (well within the precipita- 
tion zone) and remove the precipitate between the antibody and the 
lung filtrate (or broth filtrate) before adding these substances to the 
blood--see third column, Table IV. 
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The action of the convalescent blood on these filtrates is difficult to 
explain.  It  is  weak in  precipitin  (anficarbohydrate antibody)  but 
neutralizes the filtrates, whereas a similar concentration of precipitin 
in  an  artificial mixture of normal blood  and  dilute  antiserum  (see 
Column 3 in Tables I and III) has no neutralizing action.  This would 
point to the presence of another unknown antibody in the convalescent 
blood, were it not that in stronger concentration the antiserum has a 
neutralizing antibody for the filtrates, which is presumably the anti- 
carbohydrate antibody,  since its neutralizing action is weakened by 
absorbing  the  antiserum  with  the  carbohydrate.  The  problem  is 
complicated and puzzling as it is left in this stage, but it is possible 
that the clue to Type III serum therapy lies hidden in the maze.  The 
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that the neutralizing antibody present in the convalescent blood differs 
in  some subtle  way from the  neutralizing antibody present in  the 
antiserum.  As an explanation, this is admittedly weak and unsatis- 
factory.  However, it must be borne in mind that the stimulus to the 
production of antibodies is different  in the two cases.  In the artificially 
produced antiserum, the stimulus is first dead pneumococci and later 
living pneumococci, which are no doubt  soon  killed after they are 
injected into  the  horse.  In  the  actual  disease the  stimulus is  the 
organism  growing,  multiplying,  and  later  autolyzing in  the lesion. 
Obviously the first point to determine is whether the active substance 
in the lung filtrate is antigenic.  All previous experience is against this 
possibility,  type-specific antibodies being apparently produced only 
by intact pneumococci.  Nevertheless this question is being investi- 
gated once more, although with no great optimism, and so far with no 
Success. 
Two other specimens of Type III convalescent blood neutralized 
the Type III broth filtrate in a  similar manner. 
A few experiments have been carried out with Type I pneumococcus. 
The filtrate of a 5 day broth culture of the Type I organism behaves 
more like the Type I  carbohydrate, its antibactericidal action being 
neutralized  by  the  weaker  concentrations  of  antiserum.  Several 
attempts have been made to grow the  organism in  fresh undiluted 
human serum.  It did not always grow very well, but whenever there 
was good growth the filtrate had a strong antibactericidal effect, and 
like the Type III lung filtrate was not neutralized by the weaker con- 
centrations of antiserum.  Up to the present, no filtrate from a lung 
of an untreated Type I pneumonia case has been available for testing. 
DISCUSSION 
Despite the great progress that has been made during the last decade 
in our knowledge of the pneumococcus, the mechanism of infection 
and resistance is not yet deafly understood.  In any theory of im- 
munity, proof or disproof must of course in the end rest on animal 
experimentation, but this method of investigation has disadvantages 
in attempting an analysis of the mechanism of immunity, because the 
various factors cannot be separated or their quantitative relationship 
studied, save with the greatest difficulty.  It is in this field of analysis HUOH ~.  WARD  529 
that  the  bactericidal  technique can  be  used  with  advantage,  if its 
obvious limitations are borne in mind. 
One can hardly doubt that the problem of virulence and resistance 
in the case of the pneumococcus centers round the specific carbohydrate 
and its specific antibody.  Accordingly it is very desirable to under- 
stand how these substances react with one another in pneumococcal 
infection, and in defibrinated human blood the conditions are fairly 
similar, though of course not identical with those that pertain in the 
living  body.  It  has  been possible  to  demonstrate by  this  method 
the following facts. 
1.  That a  serum which gives a  negative precipitin test  (using the 
specific carbohydrate as the precipitinogen) may still have a consider- 
able antibody content against the specific carbohydrate.  Accordingly 
it is unjustifiable to assume that an animal or human being has no 
type-specific  immunity  against  a  type  pneumococcus  because  no 
specific precipitins can be demonstrated in the serum. 
2.  That  the  antibactericidal  action  of  the  specific  carbohydrate, 
though definite, is seen to be very weak, when the small amount of the 
polysaccharide that is  present in  an  autolyzed culture is taken into 
account.  If the actual carbohydrate is present in the body in pneu- 
monia, it is difficult to see how there could possibly be sufficient to in- 
fluence the course of the disease. 
3.  That in the filtrate of an autolyzed broth culture of Type III 
pneumococcus, and more significant still, in the filtrate of a  lung ob- 
tained at autopsy from a patient dead of Type III pneumonia, there 
could be demonstrated a type-specific substance which has a far more 
powerful antibactericidal action than the purified carbohydrate.  This 
substance appears to be related to the specific carbohydrate, and its 
nature and possible influence on the disease have been discussed in the 
text. 
4.  That as far as the evidence from three specimens of convalescent 
blood goes--and that is admittedly not far--the blood just after crisis 
appears  to  be  more efficient in  neutralizing  the  autolysate  than  a 
corresponding mixture of normal blood and antiserum.  If this  can 
be confirmed, it may eventually throw some light on the problem of 
serum therapy.  No adequate explanation has yet been offered of why 
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of Types I  and II pneumonia, is ineffective at any stage in Type III 
pneumonia, while the natural crisis occurs much later in the disease. 
In attacking the baffling  problem of pneumococcal immunity by 
investigating the  functions of  the  pneumococcal products  and  the 
neutralizing action of the antiserum on these products, one is but doing 
in  pneumonia what was done many years ago  in  diphtheria.  The 
details in the two problems are very different, but broadly speaking 
the products of each organism are its defences, as the respective anti- 
serums are the main defences of the host.  Unfortunately we cannot 
attack the toxemia of pneumonia directly as we can in diphtheria, but 
the experiments with the lung filtrate indicate that the products of the 
pneumococcus have to be reckoned with, even though they are not 
themselves toxic to the body cells. 
CONCLUSIONS 
1.  There is in the filtrate of a 5 day broth culture of Type III pneu- 
mococcus a  type-specific substance which has a  very powerful anti- 
bactericidal action.  If the precipitinogen content of the broth filtrate 
and the specific carbohydrate is taken as the basis of comparison, it 
requires  approximately one  thousand  times as  much antiserum to 
neutralize the broth filtrate as is necessary to neutralize the specific 
carbohydrate.  The active substance in the broth filtrate appears to 
be  related to  the specific  carbohydrate.  Its possible  nature is  dis- 
cussed. 
2.  A similar substance, but in stronger concentration, was found in 
the filtrate of a lung from a Type III pneumonia autopsy.  The in- 
fluence of this substance on the disease is discussed. 
3.  One specimen of Type III convalescent blood,  though compara- 
tively weak in anticarbohydrate antibody (precipitin) was better able 
to neutralize the broth filtrate and the lung filtrate than a correspond- 
ing mixture of normal blood  and antiserum.  Two other specimens 
of Type II convalescent blood neutralized the Type III broth filtrate 
efficiently. 
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